clinical assessment in elderly patient undergoing cancer chemotherapy
Not Applicable
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Registration Number
- CTRI/2020/04/024675
- Lead Sponsor
- ot Applicable
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Age 60 years and over
2. Diagnosis of malignancy
3. ECOG performance status 0 to 3, i.e. patient not completely disabled
Exclusion Criteria
1. Patient or caregiver refusal to undergo assessment.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To describe the profile of the patients evaluated at the geriatric oncology clinic at Tata Memorial Center. This description will include the: <br/ ><br>1.The incidence of vulnerabilities in the domains of function, falls, comorbidities, social, psychological, cognition and nutrition. <br/ ><br>2.The incidence of polypharmacy and of potentially inappropriate medications.Timepoint: At the baseline comprehensive geriatric assessment.
- Secondary Outcome Measures
Name Time Method To describe the: <br/ ><br>1.Time taken to perform the comprehensive geriatric assessment. <br/ ><br>2.Acceptability and feasibility of the various self-administered questionnaires for our patients. <br/ ><br>3.To assess if various short screening tools like G8, VAS and TRST can predict for the presence of an abnormality in the comprehensive geriatric assessment. <br/ ><br>4.The chemotherapy risk assessment profile of the patients. <br/ ><br>5.Quality of life of geriatric oncology patients and caregivers.Timepoint: At the baseline comprehensive geriatric oncology assessment